Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Essen
Clinical trial register · Germany

Clinical Trials in Essen, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Germany and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5082 matching records held by the registry are in this view. Synced 17 Nov 2026, 03:18 UTC
5082
Studies in scope
all four open statuses
2886
Recruiting now
open to new participants
989
Lead sponsors
across recruiting studies
Top sites
Bad Segeberg 2 Kempten 2 Neuss 2 Tübingen 2 Minden 1
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca60 Novartis Pharmaceuticals50 Eli Lilly and Company32 Amgen26 Hoffmann-La Roche26 University Hospital, Essen25 Janssen Research & Development, LLC22 Merck Sharp & Dohme LLC21 Bristol-Myers Squibb14 Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest13 GlaxoSmithKline12 Sanofi11 Novo Nordisk A/S10 argenx9 Alexion Pharmaceuticals, Inc.9 Boehringer Ingelheim9 Pfizer9 Universität Duisburg-Essen8 Daiichi Sankyo8 Incyte Corporation6 Technische Universität Dresden6 Regeneron Pharmaceuticals6 Gilead Sciences6 European Organisation for Research and Treatment of Cancer - EORTC6 AbbVie5 Genmab5 MedSIR5 German Cancer Research Center5 Vertex Pharmaceuticals Incorporated5 Sarepta Therapeutics, Inc.4 Bayer4 University Hospital, Basel, Switzerland4 University Hospital Tuebingen4 Universitätsklinikum Hamburg-Eppendorf4 Kliniken Essen-Mitte4 Celgene4 Philogen S.p.A.4 Princess Maxima Center for Pediatric Oncology4 Boston Scientific Corporation3 M.A. Med Alliance S.A.3 AGO Research GmbH3 AIO-Studien-gGmbH3 Replimune, Inc.3 Jena University Hospital3 Astellas Pharma Global Development, Inc.3 Genentech, Inc.3 CatalYm GmbH3 Swedish Orphan Biovitrum3 ViiV Healthcare3 Heidelberg University3 Edwards Lifesciences3 University Hospital Heidelberg3 Biogen3 Juno Therapeutics, Inc., a Bristol-Myers Squibb Company3 Universität Münster3 Abiomed Inc.3 Deciphera Pharmaceuticals, LLC3 Institut de Recherches Internationales Servier2 Helios Health Institute GmbH2 Fondazione IRCCS Istituto Nazionale dei Tumori, Milano2 Charite University, Berlin, Germany2 Loxo Oncology, Inc.2 German CLL Study Group2 Ataxia Study Group2 IDEAYA Biosciences2 Tesaro, Inc.2 United Therapeutics2 Insel Gruppe AG, University Hospital Bern2 Population Health Research Institute2 CytoSorbents, Inc2 Italfarmaco2 Hannover Medical School2 Immunocore Ltd2 Agios Pharmaceuticals, Inc.2 Medtronic Cardiovascular2 BioNTech SE2 Exelixis2 EMD Serono Research & Development Institute, Inc.2 IO Biotech2 medac GmbH2 Kailera2 Ipsen2 BeOne Medicines2 Alnylam Pharmaceuticals2 North Eastern German Society of Gynaecological Oncology2 ITM Solucin GmbH2 Weill Medical College of Cornell University2 GBG Forschungs GmbH2 Ascletis Pharma (China) Co., Limited2 Goethe University2 Jules Bordet Institute1 University of Ulm1 Biosense Webster, Inc.1 Vico Therapeutics B. V.1 VectivBio AG1 Scholar Rock, Inc.1 Swiss GO Trial Group1 Swiss Cancer Institute1 Cardiovascular and Interventional Radiological Society of Europe1 Tom Hühne1 University of Jena1 Institut National de la Santé Et de la Recherche Médicale, France1 Day One Biopharmaceuticals, Inc.1 Bellus Health Inc. - a GSK company1 iOMEDICO AG1 Ad scientiam1 JOTEC GmbH1 SymBio Pharmaceuticals1 Philips Clinical & Medical Affairs Global1 Research Center Borstel1 Arcus Biosciences, Inc.1 Philipp Dutkowski1 BicycleTx Limited1 Napo Therapeutics, S.p.A.1 XEOS Medical1 Verastem, Inc.1 University Medical Center Groningen1 Revolution Medicines, Inc.1 Shockwave Medical, Inc.1 Rolfs Consulting und Verwaltungs-GmbH (RCV)1 Biotronik AG1 Protara Therapeutics1 Aura Biosciences1 Pulmonx Corporation1 Oliver Cornely, MD1 Immunovant Sciences GmbH1 HepaRegeniX GmbH1 Intuitive Surgical1 Nikolaj Frost MD1 Harmony Biosciences Management, Inc.1 Tobias Feuchtinger1 Advanced Accelerator Applications1 Mayo Clinic1 Hemovent GmbH1 Medtronic1 Uptake Medical Technology, Inc.1 ResMed1 Javelin Medical1 Sebastian Probst1 Dr. Andreas Ziegler1 Isofol Medical AB1 Alentis Therapeutics AG1 NovoCure GmbH1 Molecure S.A.1 Heinrich-Heine University, Duesseldorf1 Deutsches Herzzentrum Muenchen1 Vicore Pharma AB1 Pentixapharm AG1 Vivet Therapeutics SAS1 Teva Branded Pharmaceutical Products R&D LLC1 IHF GmbH - Institut für Herzinfarktforschung1 AvenCell Europe GmbH1 RECORDATI GROUP1 Biohaven Pharmaceuticals, Inc.1 Associazione Italiana Ematologia Oncologia Pediatrica1 Christian Buske1 MaaT Pharma1 ETOP IBCSG Partners Foundation1 Evangelical Hospital Düsseldorf1 University of Wuerzburg1 Biotest1 Intellia Therapeutics1 Dr. Rebecca Schule1 Acrivon Therapeutics1 Prof. Dr. Paul Brinkkoetter1 Cytokinetics1 Fundación EPIC1 Avidity Biosciences, Inc.1 CarThera1 OSE Immunotherapeutics1 Celldex Therapeutics1 UMC Utrecht1 Alliance for Clinical Trials in Oncology1 Takeda1 University Eye Hospital, Freiburg1 Arbor Research Collaborative for Health1 Alcyone Therapeutics, Inc1 University Hospital, Tours1 Insmed Incorporated1 AGO Study Group1 Guerbet1 Beeline Medicines Corporation1 International Extranodal Lymphoma Study Group (IELSG)1 Camurus AB1 University of Leipzig1 UNICANCER1 Bicara Therapeutics1 Mizuho Corporation1 Integra LifeSciences Corporation1 Xenios AG1 AvenCell Therapeutics, Inc.1 Technical University of Munich1 Abbott Medical Devices1 Rede Optimus Hospitalar SA1 Elixir Medical Corporation1 TME Pharma AG1 BioInvent International AB1 Acandis GmbH1 Vifor Fresenius Medical Care Renal Pharma1 Cogent Biosciences, Inc.1 Blue Earth Therapeutics Ltd1 Federation Francophone de Cancerologie Digestive1 Britannia Pharmaceuticals Ltd.1 Leiden University Medical Center1 Miltenyi Biomedicine GmbH1 Syndax Pharmaceuticals1 Stichting Hemato-Oncologie voor Volwassenen Nederland1 Endeavor Biomedicines, Inc.1 Neurocrine Biosciences1 Crinetics Pharmaceuticals Inc.1 Prof. Dr. Martin Wabitsch1 Centre Hospitalier Universitaire de Besancon1 RWTH Aachen University1 Jazz Pharmaceuticals1 Savara Inc.1 Seagen, a wholly owned subsidiary of Pfizer1 Alliance Foundation Trials, LLC.1 Women's Cancer Study Group GmbH1 Italian Sarcoma Group1 University of Cologne1 Boris Böll1 European Myeloma Network B.V.1 Montefiore Medical Center1 European Association of Urology Research Foundation1 Medtronic Neurovascular Clinical Affairs1 Immatics US, Inc.1 Medical University Innsbruck1 OncoC4, Inc.1 Viridian Therapeutics, Inc.1 Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company1 St. Josefs-Hospital Wiesbaden GmbH1 LivaNova1 St. Anna Kinderkrebsforschung1 Institut für Pharmakologie und Präventive Medizin1 Vividion Therapeutics, Inc.1 Rigel Pharmaceuticals1 Michael Dill1 Akeso1 Kite, A Gilead Company1 Liquidia Technologies, Inc.1 Adcendo ApS1 Sied Kebir1 UCB Biopharma SRL1 Dr. Paul Buderath1 Janssen Pharmaceutica N.V., Belgium1 Astellas Gene Therapies1 Prof. Dr. Dr. Birgit Burkhardt1 Leipzig Heart Science gGmbH1 University Medical Center Nijmegen1 University of Witten/Herdecke1 dr. M.J.N.L. Benders1 LEO Pharma1 SystImmune Inc.1 Avalyn Pharma Inc.1 TheraOp1 IDRX, Inc., a wholly owned subsidiary of GSK, LLC1 ExThera Medical Corporation1 Mirum Pharmaceuticals, Inc.1 DKMS gemeinnützige GmbH1 Corcym S.r.l1 Octapharma1 PMV Pharmaceuticals, Inc1 Vir Biotechnology, Inc.1 Microvention-Terumo, Inc.1 Mirati Therapeutics Inc.1 HUYABIO International, LLC.1 SecuraBio1 Clear sponsor filter
Target enrolment
to

Trials with a site in Essen

1 of 5082 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Germany
Start
Active, closed
Biotronik AG
Observational
160
Bayreuth, Essen, Flensburg, Jena, Münster, Tübingen
2021-08-10
Rows per page Showing 1–1 of 1
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a German investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 19 November 2026. https://priyalifescience.com/clinical-trials-germany/city/essen

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Germany and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,082 studies in total at the last sync on 17 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 1 of those studies with a site in Essen that also match the filters currently applied.

How many clinical trials are recruiting in Essen?

0 of the 1 studies on this page are recruiting new participants as of the 17 Nov 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 1 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Essen), 1 studies
PhaseStudiesRecruitingShare
Observational10100%

Most active sponsors

Lead sponsors with the most studies (Essen)
Lead sponsorStudiesRecruiting
Biotronik AG10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.